Skip Navigation

Radiofrequency volumetric tissue reduction of turbinate hypertrophy

Guidance issued Guidance issued
 
IP Guidance Number: IPG36
 
Summary:

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on radiofrequency volumetric tissue reduction of turbinate hypertrophy.

Description:

In the inside of each nostril there are bony projections called turbinates. Turbinates increase the surface area of the inside of the nose, improving its air-filtering functions. There are three turbinates (inferior, middle, and superior) on each side of the nose. Swelling of the inferior turbinates (turbinate hypertrophy) can lead to blockage of nasal breathing (turbinate dysfunction).

Radiofrequency volumetric tissue reduction for turbinate hypertrophy is an outpatient procedure in which a submuscosal scar is created by the use of a needle electrode inserted into soft tissue.

The procedure involves the injection of a local anaesthetic. A needle electrode is then placed into the anterior inferior turbinate where the radiofrequency energy is delivered by a power generator. There is a variation in the energy levels and temperatures used.

Arrangements:

Special

Topic Area:

Ear and nose
Surgical procedures

Specialty:

General surgery

Specialist advice has
been sought from:
British Association of Otorhinolaryngologists
Date notified to NICE: 26 February 2003
Guidance Publication Date: 28 January 2004
Contact Details:
Project Manager
(for general enquiries or comments)
Ben Doak
Technical Lead
(for procedure specific enquiries or comments)
Sally Wortley
ip@nice.hs.uk
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA


Links:

Search NICE guidance


Advanced guidance search

Related guidance

Click the links below to see guidance on similar topics